Particulate Composition
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 63/550,786, filed Feb 7, 2024. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,194,045 | Particulate Composition In force · High confidence | Verona Pharma Limited | In force | High confidence | ||
| US 12,251,384 | Particulate Composition In force · High confidence | Verona Pharma Limited | In force | High confidence | ||
| Application 19/039,271 | Particulate Composition Pending Not granted | Verona Pharma Limited | Pending | Not granted |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Verona Pharma Limited.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.